Table 7.
Factor | p Value | Odds ratio (95% Wald CI) |
---|---|---|
Pre-AI clinical T stage (3/4 versus 2) | 0.012 | 3.67 (1.3–10.1) |
Pre-AI surgical status (others versus marginal) | 0.019 | 3.21 (1.2–8.5) |
Post-AI cT stage (2/3/4 versus 1/0) | 0.029 | 3.3 (1.1–9.4) |
AI, aromatase inhibitor.